Cited by

• Immune Response, Inflammation, and the Clinical Spectrum of COVID-19.

  García LF. García LF. Front Immunol. 2020 Jun 16;11:1441. doi: 10.3389/fimmu.2020.01441. eCollection 2020. Front Immunol. 2020. PMID: 32612615 Free PMC article. Review.
• Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.

  National SARS-CoV-2 Serology Assay Evaluation Group. National SARS-CoV-2 Serology Assay Evaluation Group. Lancet Infect Dis. 2020 Dec;20(12):1390-1400. doi: 10.1016/S1473-3099(20)30634-4. Epub 2020 Sep 23. Lancet Infect Dis. 2020. PMID: 32979318 Free PMC article.
• Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies.

  Charlton CL, Kanji JN, Johal K, Bailey A, Plitt SS, MacDonald C, Kunst A, Buss E, Burnes LE, Fonseca K, Berenger BM, Schnabl K, Hu J, Stokes W, Zelyas N, Tipples G. Charlton CL, et al. J Clin Microbiol. 2020 Sep 22;58(10):e01361-20. doi: 10.1128/JCM.01361-20. Print 2020 Sep 22. J Clin Microbiol. 2020. PMID: 32665420 Free PMC article.
• Application of Nanomaterials as an Advanced Strategy for the Diagnosis, Prevention, and Treatment of Viral Diseases.

  Lim JW, Ahn YR, Park G, Kim HO, Haam S. Lim JW, et al. Pharmaceutics. 2021 Sep 27;13(10):1570. doi: 10.3390/pharmaceutics13101570. Pharmaceutics. 2021. PMID: 34683863 Free PMC article. Review.
• A reduced graphene oxide-Fe₃O₄ composite functionalized with cetyltrimethylammonium bromide for efficient adsorption of SARS-CoV-2 spike pseudovirus and human enteric viruses.

  Zhou S, Jin M, Tan R, Shen Z, Yin J, Qiu Z, Chen Z, Shi D, Li H, Yang Z, Wang H, Gao Z, Li J, Yang D. Zhou S, et al. Chemosphere. 2022 Mar;291(Pt 3):132995. doi: 10.1016/j.chemosphere.2021.132995. Epub 2021 Nov 19. Chemosphere. 2022. PMID: 34808196 Free PMC article.